Company intelligence / Profile preview

Meditrix

Ownership: Private
Development stage: Commercial

Overview

Meditrix is a Tokyo-based full-service CRO specializing in pre-market and post-market clinical studies of medical devices. The company provides site selection, monitoring, data management, statistics, adverse event management, quality assurance audits, regulatory consulting, and uses its proprietary electronic data capture system. It serves both domestic Japanese medtech companies and international firms seeking access to the Japanese market. Meditrix has received investment from Belgian CRO genae but remains independent as of the latest reports.

Therapeutic areas: Other
Modalities: Device
Industry: Contract Research Organization

Partnerships

genae (Belgian CRO with strategic investment/partnership in Japan)

Beyond the preview

Go deeper on Meditrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meditrix.

Explore the full profile